1. |
Wu J, Yang S, Xu K, et al. Patterns and trends of liver cancer incidence rates in Eastern and Southeastern Asian countries (1983-2007) and predictions to 2030. Gastroenterology, 2018, 154(6): 1719-1728. e5.
|
2. |
Lurje G, Bednarsch J, Czigany Z, et al. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent. Langenbecks Arch Surg, 2018, 403(7): 851-861.
|
3. |
de Santibañes E, Clavien PA. Playing play-doh to prevent postoperative liver failure: the “ALPPS” approach. Ann Surg, 2012, 255(3): 415-417.
|
4. |
Clavien PA, de Santibañes E. The ALPPS: time to explore. Ann Surg, 2012, 25: e18-e19.
|
5. |
Kang D, Schadde E. Hypertrophy and liver function in ALPPS: correlation with morbidity and mortality. Visc Med, 2017, 33(6): 426-433.
|
6. |
国家卫生健康委办公厅. 原发性肝癌诊疗指南 (2022年版). 中华外科杂志, 2022, 60(4): 273-308.
|
7. |
Pandanaboyana S, Bell R, Hidalgo E, et al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery, 2015, 157(4): 690-698.
|
8. |
Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg, 2013, 217(1): 126-133.
|
9. |
Sandström P, Røsok BI, Sparrelid E, et al. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian multicenter randomized controlled trial (LIGRO Trial). Ann Surg, 2018, 267(5): 833-840.
|
10. |
Li J, Yang GS, Sun KJ, et al. Clinical evaluation of modified ALPPS procedures based on risk-reduced strategy for staged hepatectomy. Ann Hepatol, 2021, 20: 100245. doi: 10.1016/j.aohep.2020.08.063.
|
11. |
Vennarecci G, Grazi GL, Sperduti I, et al. ALPPS for primary and secondary liver tumors. Int J Surg, 2016, 30: 38-44.
|
12. |
Xiang F, Hu ZM. Chance and challenge of associating liver partition and portal vein ligation for staged hepatectomy. Hepatobiliary Pancreat Dis Int, 2019, 18(3): 214-222.
|
13. |
Tong YF, Meng N, Chen MQ, et al. Maturity of associating liver partition and portal vein ligation for staged hepatectomy-derived liver regeneration in a rat model. World J Gastroenterol, 2018, 24(10): 1107-1119.
|
14. |
Zhang Y, Zheng Y, Dong X, et al. Associating liver partition and portal vein ligation for staged hepatectomy versus conventional staged hepatectomy: a meta-analysis. Minerva Med, 2018, 109(2): 141-149.
|
15. |
Baili E, Tsilimigras DI, Filippou D, et al. Associating liver partition and portal vein ligation for staged hepatectomy in patients with primary liver malignancies: a systematic review of the literature. J BUON, 2019, 24(4): 1371-1381.
|
16. |
Cillo U, Gringeri E, Feltracco P, et al. Totally laparoscopic microwave ablation and portal vein ligation for staged hepatectomy: a new minimally invasive two-stage hepatectomy. Ann Surg Oncol, 2015, 22(8): 2787-2788.
|
17. |
杨涛, 杜锡林, 贺小军, 等. 微波消融治疗在ALPPS术中的临床应用. 现代肿瘤医学, 2016, 24(17): 2744-2747.
|
18. |
刘佳, 刘俊, 朱坪. 射频消融辅助改良ALPPS术治疗老年原发性肝癌的临床效果及对术后局部复发的影响. 中国肿瘤外科杂志, 2022, 14(1): 89-93.
|